Search

everythinglearnresearchcommunity

for

Search:↓

Hyperpigmentation is common in pregnancy and may not fully fade after birth; melasma, also frequent, can persist but has limited treatment options during pregnancy.

A 73-year-old man's grey-white hair turned dark brown after eczema treatment.

Segmental Vitiligo is a stable, early-onset form of vitiligo that responds well to early treatment and is ideal for repigmentation studies.

Using 2% tofacitinib cream with narrowband ultraviolet B improved facial vitiligo by 70% in patients who didn't respond to previous treatments, with no side effects reported.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

The document concludes that low-dose acne treatment is most suitable for moderate acne, with high patient satisfaction and low relapse rates.

The meeting discussed vitamin D3's role in fighting tuberculosis, potential treatments for skin conditions like psoriasis, and hair follicle regeneration as a possible solution for hair loss.

The skin's internal clock affects healing, cancer risk, aging, immunity, and hair growth, and disruptions can harm skin health.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Most clinicians follow discharge guidelines, many lupus patients don't use sunscreen regularly, dithranol is effective for psoriasis, biopsy methods should be based on lesion type, voriconazole may raise skin cancer risk, a new scale can help diagnose female hair loss early, and most melanomas may develop from existing moles.

Finasteride is effective for male hair loss, teledermatology is accurate and accepted, and cyclosporin helps treat toxic epidermal necrolysis.

A3B5 can reduce skin pigmentation and slow melanoma growth.

Combination therapies might work better for some vitiligo patients, but results vary.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

Photobiomodulation therapy may help treat hair loss in people with darker skin, but more research is needed.

People respond differently to hair loss treatment with PRP because of individual differences in growth factors from platelets.

New psoriasis treatments are effective but come with side effects and risks.

Narrowband UVB treatment increases certain gene expressions in psoriasis skin and improves symptoms.

Photodynamic therapy can remove nonpigmented hair in mice and might work for humans.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Cell therapy shows promise for treating severe psoriasis but needs more research to confirm safety and effectiveness.

Skin treatment can lower life quality for patients with skin conditions.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

The document concludes that individualized treatment for malignant epithelial tumors is necessary and more research on metastatic squamous cell carcinoma treatments is needed.

Cancer rates are increasing in developed countries, with estrogen, aging, low vitamin D3, and HPV infection as common causes.